Creighton Univeristy
Omaha, Nebraska, 68178, United States
NCT Number: NCT03883971
This study will invite healthy women with singleton pregnancies and normal 20 week ultrasounds to participate in the study that will involve completing a demographic questionnaire and measure of attachment, a 3D ultrasound, being randomized to receive a 3D printed model of the fetal face or not, and completing the attachment measure again.
Looking for future studies?
Notify Me19 year–45 year
Female
Interventional
Not applicable
Omaha, Nebraska, 68178, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Same as previously reported in arm descriptions
nothing other than the ultrasound
Time frame: 5 minutes
The MAAS is a 19 item questionnaire measuring maternal-fetal attachment. Each item has five answer choices scored from 1 low attachment to 5 high attachment such that the total score ranges from 19 to 95. The measure also includes two subscales: (1) Quality of Attachment has 10 items with a range of 10-50 and measures the quality of the mother's attachment to her fetus. (2) Time measures the time spent in attachment mode (or intensity of preoccupation) and consists of 8 items for a range of 8 to 40. (for clarity one item included in the total score is not included in either subscale.)
Creighton University
Other
Effects of 3D Printing Technology on Maternal Fetal Bonding Compared to 2D/3D Ultrasounds
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06480916
Maternal-Fetal Relations
Briey, France
View Trial DetailsNCT07268014
Birth, First, Female Urogenital Diseases
Konya, Turkey (Türkiye)
View Trial DetailsNCT06892665
Cardiovascular Diseases, Cesarean Section Complications
Cheras, Kuala Lumpur, Malaysia
View Trial DetailsNCT05856396
Bacterial Infections, Bacterial Infections and Mycoses
Brussels, Belgium
View Trial Details